A PET study of serotonin transporter, activated microglia and energy metabolism measerment of the brain in Chronic Fatigue Syndrome.

A PET study of serotonin transporter, activated microglia and energy metabolism measerment of the brain in Chronic Fatigue Syndrome. - A PET study of serotonin transporter, activated microglia and energy metabolism of the brain in Chronic Fatigue Syndrome.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005469

Enrollment

Registered

2011-04-20

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Fatigue Syndrome

Interventions

DASB, PK11195, FDG PET DASB, PK11195, FDG PET

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with Chronic fatigue syndrome diagnosed in Osaka City University Hospital and healthy indivisuals, who give imformed consent

Exclusion criteria

Exclusion criteria: Participants 1) with past or current history of serious medical illness and/or brain organic disease 2) with pregnancy women 3) who take central nerve system acting drugs, such as autonomic drugs and antidepressants 4) who is contradicated for the use of MRI 5) who are judged as not suitable for participation in this study

Design outcomes

Primary

Measure	Time frame
Binding potential of DASB or PK11195 by PET	—

Countries

Japan

Contacts

Public ContactYasuhito Nakatomi

Osaka City University Graduated School of Medicine Metabolism, Endocrinology and Molecular Medicine

nakatomi@med.osaka-cu.ac.jp06-6646-3033

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026